Product NDC: | 0781-3010 |
Proprietary Name: | Ondansetron |
Non Proprietary Name: | Ondansetron |
Active Ingredient(s): | 2 mg/mL & nbsp; Ondansetron |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0781-3010 |
Labeler Name: | Sandoz Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA077551 |
Marketing Category: | ANDA |
Start Marketing Date: | 20070627 |
Package NDC: | 0781-3010-95 |
Package Description: | 10 VIAL, SINGLE-DOSE in 1 CARTON (0781-3010-95) > 2 mL in 1 VIAL, SINGLE-DOSE (0781-3010-72) |
NDC Code | 0781-3010-95 |
Proprietary Name | Ondansetron |
Package Description | 10 VIAL, SINGLE-DOSE in 1 CARTON (0781-3010-95) > 2 mL in 1 VIAL, SINGLE-DOSE (0781-3010-72) |
Product NDC | 0781-3010 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Ondansetron |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 20070627 |
Marketing Category Name | ANDA |
Labeler Name | Sandoz Inc |
Substance Name | ONDANSETRON HYDROCHLORIDE |
Strength Number | 2 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Serotonin 3 Receptor Antagonists [MoA],Serotonin-3 Receptor Antagonist [EPC] |